Offsets |
Jan. 21, 2026
USD ($)
|
|---|---|
| Offset: 1 | |
| Offset Payment: | |
| Offset Claimed | true |
| Rule 457(b) Offset | true |
| Form or Filing Type | S-1 |
| File Number | 333-287963 |
| Initial Filing Date | Jun. 11, 2025 |
| Fee Offset Claimed | $ 2,269.90 |
| Explanation for Claimed Amount | In accordance with Rule 457(b) under the Securities Act, the Company is using $2,269.90 of the previously paid fees to offset the filing fee payable in connection with this amendment to this Registration Statement. |
| Offset: 2 | |
| Offset Payment: | |
| Offset Claimed | false |
| Rule 457(b) Offset | true |
| Registrant or Filer Name | GT Biopharma, Inc. |
| Form or Filing Type | S-1 |
| File Number | 333-287963 |
| Filing Date | Jun. 11, 2025 |
| Fee Paid with Fee Offset Source | $ 2,269.90 |
| Explanation for Claimed Amount | In accordance with Rule 457(b) under the Securities Act, the Company is using $2,269.90 of the previously paid fees to offset the filing fee payable in connection with this amendment to this Registration Statement. |